Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30285% above fair value
$143.37−1.09 (-0.75%)
Close on Nov 17, 2026Market cap $353.72BP/E 114.7Yield 2.29%
Merck cash
Cash and short-term investments held at the end of each period.
Merck's cash was $7.14B at Jun 30, 2026. For fiscal 2025 it was $14.57B, up 5.8% from the year before. Over ten years it grew 0.8% a year on average. The highest annual figure on record is $17.49B in fiscal 2013.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.57B | +5.8% |
| FY2024 | Dec 31, 2024 | $13.77B | +92.2% |
| FY2023 | Dec 31, 2023 | $7.16B | -46.0% |
| FY2022 | Dec 31, 2022 | $13.27B | +62.5% |
| FY2021 | Dec 31, 2021 | $8.17B | +0.2% |
| FY2020 | Dec 31, 2020 | $8.15B | -23.9% |
| FY2019 | Dec 31, 2019 | $10.71B | +20.8% |
| FY2018 | Dec 31, 2018 | $8.87B | +4.3% |
| FY2017 | Dec 31, 2017 | $8.50B | -40.7% |
| FY2016 | Dec 31, 2016 | $14.34B | +6.8% |
| FY2015 | Dec 31, 2015 | $13.43B | -14.6% |
| FY2014 | Dec 31, 2014 | $15.72B | -10.1% |
| FY2013 | Dec 31, 2013 | $17.49B | +8.3% |
| FY2012 | Dec 31, 2012 | $16.14B | +7.8% |
| FY2011 | Dec 31, 2011 | $14.97B | +22.7% |
| FY2010 | Dec 31, 2010 | $12.20B | +27.0% |
| FY2009 | Dec 31, 2009 | $9.60B | +75.1% |
| FY2008 | Dec 31, 2008 | $5.49B | +2.8% |
| FY2007 | Dec 31, 2007 | $5.34B | -9.8% |
| FY2006 | Dec 31, 2006 | $5.91B | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.14B | -17.8% |
| Q1 FY2026 | Mar 31, 2026 | $5.70B | -38.9% |
| Q4 FY2025 | Dec 31, 2025 | $14.57B | +5.8% |
| Q3 FY2025 | Sep 30, 2025 | $18.21B | +24.0% |
| Q2 FY2025 | Jun 30, 2025 | $8.69B | -23.9% |
| Q1 FY2025 | Mar 31, 2025 | $9.33B | +63.4% |
| Q4 FY2024 | Dec 31, 2024 | $13.77B | +92.2% |
| Q3 FY2024 | Sep 30, 2024 | $14.69B | +66.2% |
| Q2 FY2024 | Jun 30, 2024 | $11.42B | +77.7% |
| Q1 FY2024 | Mar 31, 2024 | $5.71B | -45.4% |
| Q4 FY2023 | Dec 31, 2023 | $7.16B | -46.0% |
| Q3 FY2023 | Sep 30, 2023 | $8.84B | -22.4% |
| Q2 FY2023 | Jun 30, 2023 | $6.43B | -37.0% |
| Q1 FY2023 | Mar 31, 2023 | $10.47B | +16.5% |
| Q4 FY2022 | Dec 31, 2022 | $13.27B | +62.5% |
| Q3 FY2022 | Sep 30, 2022 | $11.38B | +13.3% |
| Q2 FY2022 | Jun 30, 2022 | $10.21B | +18.3% |
| Q1 FY2022 | Mar 31, 2022 | $8.99B | +30.6% |
| Q4 FY2021 | Dec 31, 2021 | $8.17B | +0.2% |
| Q3 FY2021 | Sep 30, 2021 | $10.05B | +35.7% |
| Q2 FY2021 | Jun 30, 2021 | $8.63B | -22.6% |
| Q1 FY2021 | Mar 31, 2021 | $6.88B | -7.8% |
| Q4 FY2020 | Dec 31, 2020 | $8.15B | -23.9% |
| Q3 FY2020 | Sep 30, 2020 | $7.40B | -7.7% |
| Q2 FY2020 | Jun 30, 2020 | $11.15B | +56.9% |
| Q1 FY2020 | Mar 31, 2020 | $7.47B | -15.1% |
| Q4 FY2019 | Dec 31, 2019 | $10.71B | +20.8% |
| Q3 FY2019 | Sep 30, 2019 | $8.02B | -22.0% |
| Q2 FY2019 | Jun 30, 2019 | $7.11B | -6.5% |
| Q1 FY2019 | Mar 31, 2019 | $8.80B | +19.7% |
| Q4 FY2018 | Dec 31, 2018 | $8.87B | +4.3% |
| Q3 FY2018 | Sep 30, 2018 | $10.29B | -8.1% |
| Q2 FY2018 | Jun 30, 2018 | $7.60B | -36.5% |
| Q1 FY2018 | Mar 31, 2018 | $7.35B | -51.8% |
| Q4 FY2017 | Dec 31, 2017 | $8.50B | -40.7% |
| Q3 FY2017 | Sep 30, 2017 | $11.20B | -14.3% |
| Q2 FY2017 | Jun 30, 2017 | $11.97B | – |
| Q1 FY2017 | Mar 31, 2017 | $15.25B | – |
| Q4 FY2016 | Dec 31, 2016 | $14.34B | – |
| Q3 FY2016 | Sep 30, 2016 | $13.07B | – |
See a number that looks wrong?